Adequacy of the Indication of Lipid Lowering Treatment in Primary Prevention

NACompletedINTERVENTIONAL
Enrollment

60,000

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Cardiovascular Diseases
Interventions
OTHER

Information Support System

Practitioners in the intervention group may have access, whenever they want and through the computerized medical record program, to personalized information on their assigned patients who have started treatment of cardiovascular primary prevention with lipid-lowering. This information is updated monthly for 12 consecutive months.Information will be presented in two different and complementary ways to each practitioner: asynchronous information (the patient is not present when the practitioner receives the information) and synchronous information (the patient is present when the practitioner receives the information).

Trial Locations (1)

08007

IDIAP Jordi Gol, Barcelona

All Listed Sponsors
collaborator

Preventive Services and Health Promotion Research Network

OTHER

collaborator

Catalan Institute of Health

OTHER_GOV

lead

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

OTHER

NCT01997671 - Adequacy of the Indication of Lipid Lowering Treatment in Primary Prevention | Biotech Hunter | Biotech Hunter